Immunological Data Discovery Index
Advanced Search
identifier: 2021508
description:
epitope description:W381, G389
antigen name:Genome polyprotein
host organism:Homo sapiens
antibody name:1.6D
aggregation:
instance of dataset
availability:
available
authorizations:
registration not required
accessURL: http://www.iedb.org/reference/1027141
landingPage: http://www.iedb.org/assay/2021508
type:
Submission
dates:
2014
study type: b cell assays
subject species: Dengue virus 3
fullName:
Benjamin J. Doranz Ph.D.
Kristen M. Kahle Ph.D.
Sherri L. Swayne
Jennifer M. Pfaff
Xiaoxiao Xiang Ph.D.
Lindsey E. Bazzone
James E. Robinson MD
John S. Schieffelin MD
method:
microarray
name:
Mapping Antibody Epitopes and Functional Regions of Dengue Envelope Proteins
description:
1.6D binds the DENV Fusion Loop region and is neutralizing. This antibody epitope is described in PMID 23077306.
To obtain epitope maps at a resolution of individual amino acids for monoclonal antibodies (MAbs) directed against the immunodominant envelope protein prM/E of Dengue virus (DENV), we used a novel Shotgun Mutagenesis approach (www.integralmolecular.com; Paes et al., 2009 JACS 131: 6952-6954). Shotgun Mutagenesis provided a residue-by-residue evaluation of the interaction between the prM/E target protein and anti-DENV MAbs. A comprehensive library of mutated DENV-3 (CH53489 strain) prM/E expression plasmids (1440 individual mutants) was expressed in human cells and subjected to high-throughput analyses of antibody reactivity using microplate-based immunofluorescence assays. We have screened human anti-DENV MAbs, derived from naturally infected patients, and murine MAbs, derived from DENV reporter virus immunizations (Mattia et al., 2011 PLoS ONE 6 (11): e27252). Mutations were identified as critical to a specific MAb epitope if they did not support reactivity of the MAb, but did support reactivity of other conformation-dependent MAbs. This counter-screen strategy facilitated the exclusion of prM/E mutants that were globally or locally misfolded, or that had expression defects.